New CPMP Guideline on Plastic Primary Packaging Materials

GMP News No. 431

GMP News
30 June 2004
 

New CPMP Guideline on
Plastic Primary Packaging Materials

 
On 25 February 2004, EMEA published the draft version of the Guideline on Plastic Primary Packaging Materials for commenting by the industry until the end of August 2004. In the future, this guideline will replace the former Guideline 3AQ10a.

It is the aim of this guideline to define standard procedures for the submission of data in the procedure for a marketing authorisation for plastic primary packaging materials used for the storage of active pharmaceutical ingredients and finished drug products.

The guideline is divided into the following chapters:

  • Introduction
  • Location of documentation to be provided in the marketing authorisation application
  • Data to be submitted
  • Extraction studies
  • Interaction studies
  • Toxicological information/documentation

Another interesting feature are two appendices that list in the form of decision trees which data have to be submitted with regard to plastic packaging materials for active substances and for drug products respectively. In the case of drug products, the first distinction is made between oral use and non-oral use. The next question is whether the drug products are solid dosage forms or others.

Furthermore, the guideline indicates the data that have to appear in a specification for a plastic packaging material if the material is not described in the European Pharmacopoeia.

This new draft by EMEA is certainly a very important guideline for all those who have to do with plastic packaging materials.

You can download the draft guideline if you click here.

Author:
Dr Günter Brendelberger
CONCEPT HEIDELBERG
    

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK